Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...

A new study reveals that even low-dose, chronic exposure to air pollution can trigger liver inflammation, fibrosis, and metabolic disruptions, increasing the risk of fatty liver disease and other ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

With the increasing prevalence of non-alcoholic fatty liver disease (NAFLD ... especially in lowering the risk of developing hepatocellular carcinoma (HCC) has recently attracted considerable ...

Nonalcoholic fatty liver disease (NAFLD ... and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis.

The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ 2.75 Billion in 2024 and an impressive US$ 4.24 Billion by 2029. The ...

2022 was a proficuous year in both the nonalcoholic fatty liver disease (NAFLD ... and there were advances in personalized hepatocellular carcinoma screening in patients with NAFLD.

Hepatocytes are involved in many roles of the liver, including metabolism, detoxification, and protein synthesis. Hepatocellular carcinoma is the most common form of liver cancer. It can begin as a ...